Onderneming Cell MedX Corp OTC Bulletin Board
Aandelen
US15115X1072
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Monthly Subscriptions
58,8
%
| 0 | 60,6 % | 0 | 58,8 % | -55,85% |
eBalance Devices
41,2
%
| 0 | 39,4 % | 0 | 41,2 % | -52,33% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | -54,46% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24-11-14 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | 12/12 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 27-04-22 |
Joao da Costa
BRD | Director/Board Member | 59 | 08-06-20 |
George Adams
CHM | Chairman | 76 | 23-03-18 |
Amir Vahabzadeh
BRD | Director/Board Member | 55 | 12/12 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 24-11-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 297 236 373 | 60 447 694 ( 20,34 %) | 0 | 20,34 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,76% | 47,9 mld. | |
+46,62% | 41,42 mld. | |
-2,18% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+10,19% | 25,55 mld. | |
-20,87% | 19,27 mld. | |
-0,32% | 12,15 mld. | |
+31,04% | 12,14 mld. | |
-0,47% | 11,99 mld. |
- Beurs
- Aandelen
- Koers CMXC
- Koers
- Onderneming Cell MedX Corp